Purple Innovation, Inc. current report, 14 November 2019

Business Context and Reporting Period

Purple Innovation, Inc. (PRPL), a Delaware corporation, filed this Form 8-K on November 14, 2019. The report details the entry into a material definitive agreement regarding an underwritten secondary public offering.

Key Financial Metrics

This filing does not contain revenue, profit, cash flow, margin, debt, or liquidity metrics. The document focuses exclusively on the terms of a secondary stock offering.

  • Offering Type: Underwritten secondary public offering.
  • Shares Offered: 10,000,000 shares of Class A common stock.
  • Selling Stockholders: Tony Pearce, Terry Pearce (directors), and InnoHold, LLC (controlled by the Pearces).
  • Company Proceeds: The Company will not receive any proceeds from the Offering.
  • Over-Allotment Option: Underwriters have a 30-day option to purchase up to 1,500,000 additional shares.
  • Lock-Up Period: Selling Stockholders, the Company, and its executive officers/directors agreed not to sell securities for 90 days from November 14, 2019.

Material Changes

The primary material change is the execution of the Underwriting Agreement dated November 14, 2019, with BofA Securities, Inc. and Oppenheimer & Co. Inc. as representatives. This agreement facilitates the sale of existing shares by specific stockholders rather than the issuance of new shares by the Company.

Guidance, Outlook, and Risks

Outlook: The Offering is expected to close on or about November 19, 2019, subject to customary closing conditions.

Risks and Contingencies: The filing includes standard forward-looking statements cautioning that actual results may differ due to risks beyond management's control. Specific risks include the ability to satisfy closing conditions on a timely basis. The document references the "Risk Factors" section of the Company's Annual Report on Form 10-K (filed March 13, 2019) for a comprehensive list of uncertainties.

Investor Verification Checklist

  • Verify the final closing date of the Offering (expected November 19, 2019).
  • Confirm the final offering price per share, which is not disclosed in this 8-K summary.
  • Review the full text of the Underwriting Agreement (Exhibit 1.1) for specific indemnification and covenant details.
  • Check subsequent filings to confirm if the 1,500,000 share over-allotment option was exercised.
  • Monitor the 90-day lock-up expiration date (approximately February 12, 2020) for potential future selling pressure.